Zhengfang X. Yi

516 Jungong Road
Shanghai, 200093, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 98 publications

Targeting WFS1 overcomes KRASG12D dependency and adaptive resistance to KRAS inhibition in pancreatic cancer.

Targeting WFS1 overcomes KRASG12D dependency and adaptive resistance to KRAS inhibition in pancreatic cancer.

Journal: NPJ precision oncology

Published: October 13, 2025

Design and synthesis of novel N-phenyl-4-pyrimidine-diamine BCL6 inhibitors with anti-tumor activities.

Design and synthesis of novel N-phenyl-4-pyrimidine-diamine BCL6 inhibitors with anti-tumor activities.

Journal: Future medicinal chemistry

Published: September 22, 2025

Corrigendum to "Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer" [Neoplasia. 2014 Aug;16(8):665-77].

Corrigendum to "Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer" [Neoplasia. 2014 Aug;16(8):665-77].

Journal: Neoplasia (New York, N.Y.)

Published: May 09, 2025

Design, synthesis and biological evaluation of bisnoralcohol derivatives as novel IRF4 inhibitors for the treatment of multiple myeloma.

Design, synthesis and biological evaluation of bisnoralcohol derivatives as novel IRF4 inhibitors for the treatment of multiple myeloma.

Journal: European journal of medicinal chemistry

Published: November 23, 2024

IRE1α inhibitor reduces cisplatin resistance in ovarian cancer by modulating IRE1α/XBP1 pathway.

IRE1α inhibitor reduces cisplatin resistance in ovarian cancer by modulating IRE1α/XBP1 pathway.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: October 24, 2024

Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression.

Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression.

Journal: Oncogene

Published: June 05, 2024

IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells.

IRE1α inhibitor enhances paclitaxel sensitivity of triple-negative breast cancer cells.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: May 18, 2024

A Small Molecule Selectively Targets N-Myc to Suppress Neuroblastoma Cancer Progression.

A Small Molecule Selectively Targets N-Myc to Suppress Neuroblastoma Cancer Progression.

Journal: International journal of biological sciences

Published: April 10, 2024

Selectively targeting BCL6 using a small-molecule inhibitor is a potential therapeutic strategy for glioblastoma.

Selectively targeting BCL6 using a small-molecule inhibitor is a potential therapeutic strategy for glioblastoma.

Journal: Genes & diseases

Published: February 11, 2024

A case of epilepsy and intracranial calcification caused by a variant of CLDN5 gene

A case of epilepsy and intracranial calcification caused by a variant of CLDN5 gene

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: January 24, 2024

Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the Treatment of Gastric Cancer.

Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the Treatment of Gastric Cancer.

Journal: Journal of medicinal chemistry

Published: December 06, 2023

A Small-Molecule BCL6 Inhibitor as an Anti-Proliferative Agent for Diffuse Large B-Cell Lymphoma.

A Small-Molecule BCL6 Inhibitor as an Anti-Proliferative Agent for Diffuse Large B-Cell Lymphoma.

Journal: Molecular cancer therapeutics

Published: November 25, 2023

Showing 1-12 of 98

Last Updated: 09/26/2026